Literature DB >> 17286343

Measuring economic outcomes of alcohol treatment using the Economic Form 90.

Jeremy W Bray1, Gary A Zarkin, William R Miller, Debanjali Mitra, Daniel R Kivlahan, Daniel J Martin, David J Couper, Ron A Cisler.   

Abstract

OBJECTIVE: This article assesses the ability of the economic outcome measures in the Economic Form 90 to detect differences across levels of alcohol dependence as measured by the Alcohol Dependence Scale.
METHOD: We used baseline data from the Combining Medications and Behavioral Interventions (COMBINE) Study, a large, multisite clinical trial, to assess the extent to which the economic items on the Economic Form 90 instrument can detect differences across levels of alcohol dependence.
RESULTS: After adjusting for differences in demographic characteristics, the Economic Form 90 can detect significant differences across a range of dependence severity levels for the economic outcomes of inpatient medical care, emergency-department medical care, behavioral health care, being on parole or probation, and missed workdays, conditional on being employed. We did not detect significant differences across dependence severity for employment status, outpatient medical care, other criminal justice involvement, or motor vehicle accidents.
CONCLUSIONS: The Economic Form 90 can identify differences in many economic outcomes associated with differing levels of alcohol dependence. This suggests that the Economic Form 90 may be useful in assessing changes in economic outcomes that result from changes in alcohol dependence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286343     DOI: 10.15288/jsad.2007.68.248

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  20 in total

1.  Revisiting the cost-effectiveness of the COMBINE study for alcohol dependent patients: the patient perspective.

Authors:  Laura J Dunlap; Gary A Zarkin; Jeremy W Bray; Michael Mills; Daniel R Kivlahan; James R McKay; Patricia Latham; J Scott Tonigan
Journal:  Med Care       Date:  2010-04       Impact factor: 2.983

2.  Effects of incentivizing viral suppression in previously incarcerated adults living with HIV.

Authors:  Forrest Toegel; August F Holtyn; Sarah Pollock; Andrew M Rodewald; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman
Journal:  HIV Res Clin Pract       Date:  2020-03-05

3.  Monetary conversion factors for economic evaluations of substance use disorders.

Authors:  Kathryn McCollister; Xuan Yang; Bisma Sayed; Michael T French; Jared A Leff; Bruce R Schackman
Journal:  J Subst Abuse Treat       Date:  2017-07-18

4.  An Integrative, Multilevel, and Transdisciplinary Research Approach to Challenges of Work, Family, and Health.

Authors:  Jeremy W Bray; Erin L Kelly; Leslie B Hammer; David M Almeida; James W Dearing; Rosalind B King; Orfeu M Buxton
Journal:  Methods Rep RTI Press       Date:  2013-03

5.  The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.

Authors:  Gary A Zarkin; Jeremy W Bray; Arnie Aldridge; Michael Mills; Ron A Cisler; David Couper; James R McKay; Stephanie O'Malley
Journal:  Med Care       Date:  2010-05       Impact factor: 2.983

6.  Extended-release naltrexone opioid treatment at jail reentry (XOR).

Authors:  Ryan D McDonald; Babak Tofighi; Eugene Laska; Keith Goldfeld; Wanda Bonilla; Mara Flannery; Nadina Santana-Correa; Christopher W Johnson; Neil Leibowitz; John Rotrosen; Marc N Gourevitch; Joshua D Lee
Journal:  Contemp Clin Trials       Date:  2016-05-10       Impact factor: 2.226

7.  Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON).

Authors:  Mia Malone; Ryan McDonald; Alex Vittitow; Jenny Chen; Rita Obi; Daniel Schatz; Babak Tofighi; Ann Garment; Andrea Kermack; Keith Goldfeld; Heather Gold; Eugene Laska; John Rotrosen; Joshua D Lee
Journal:  Contemp Clin Trials       Date:  2019-04-12       Impact factor: 2.226

8.  Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States.

Authors:  Gregory D Gudleski; Nikhil Satchidanand; Laura J Dunlap; Varnita Tahiliani; Xiaohua Li; Laurie Keefer; Jeffrey M Lackner
Journal:  Behav Res Ther       Date:  2017-01

9.  Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial.

Authors:  Richard Saitz; Tibor P A Palfai; Debbie M Cheng; Daniel P Alford; Judith A Bernstein; Christine A Lloyd-Travaglini; Seville M Meli; Christine E Chaisson; Jeffrey H Samet
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

10.  The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.

Authors:  Redonna K Chandler; Matthew S Finger; David Farabee; Robert P Schwartz; Timothy Condon; Laura J Dunlap; Gary A Zarkin; Kathryn McCollister; Ryan D McDonald; Eugene Laska; David Bennett; Sharon M Kelly; Maureen Hillhouse; Shannon G Mitchell; Kevin E O'Grady; Joshua D Lee
Journal:  Contemp Clin Trials       Date:  2016-05-11       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.